MedPath

Alnylam Netherlands BV

🇳🇱Netherlands
Ownership
Subsidiary
Employees
-
Market Cap
-
Website
http://www.alnylam.com/alnylam-netherlands

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

16

EMA:4
CANADA:4
CIMA_AEMPS:4

Drug Approvals

Amvuttra

Authorization Status
Authorised
Approval Date
Sep 15, 2022
EMA

Oxlumo

Authorization Status
Authorised
Approval Date
Nov 19, 2020
EMA

Givlaari

Authorization Status
Authorised
Approval Date
Mar 2, 2020
EMA

Onpattro

Authorization Status
Authorised
Approval Date
Aug 27, 2018
EMA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.